var data={"title":"Pruritus: Etiology and patient evaluation","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pruritus: Etiology and patient evaluation</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributors\" class=\"contributor contributor_credentials\">Sara B Fazio, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributors\" class=\"contributor contributor_credentials\">Gil Yosipovitch, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributors\" class=\"contributor contributor_credentials\">Jeffrey Callen, MD, FACP, FAAD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 23, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H690753\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus (itch) is a common symptom, rather than a specific disease entity, that occurs in a diverse range of skin diseases and may appear as a prominent feature of extracutaneous disorders such as systemic, neurologic, and psychiatric diseases (<a href=\"image.htm?imageKey=DERM%2F74678\" class=\"graphic graphic_table graphicRef74678 \">table 1</a>).</p><p>The pathogenesis and etiology of pruritus, as well as the evaluation of the patient with pruritus, will be reviewed here. The treatment of pruritus is discussed separately. (See <a href=\"topic.htm?path=pruritus-overview-of-management\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690760\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus is a common symptom that is experienced by all human beings at some point during the course of life. The frequent occurrence of pruritus is supported by the results of epidemiologic studies. In a large cross-sectional study (n = 11,730), chronic pruritus (pruritus persisting for more than six weeks) was reported in approximately 16 percent of German workers [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/1\" class=\"abstract_t\">1</a>]. A separate study of almost 19,000 adults in Norway found that the prevalence of pruritus in the general population was approximately 8 percent [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H690767\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the neurologic pathways that lead to itch are not fully understood, it is generally accepted that transmission of signals along unmyelinated, histamine-sensitive, and nonhistamine-sensitive peripheral C-nerve fibers (distinct from the C-nerve fibers that transmit pain) is involved. These fibers represent a minority (up to 5 percent) of C-nerve fibers in the body and are characterized by a slow conduction velocity and extensive terminal branching [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/3-8\" class=\"abstract_t\">3-8</a>]. Histamine-sensitive fibers have an important role in transmission of acute itch and itch in urticaria, while nonhistamine nerve fibers have a significant role in itch transmission of most types of chronic itch, possibly accounting for the poor response of many types of chronic itch to oral antihistamines.</p><p>Signal transmission in nerves may be stimulated by the action of a variety of neural mediators on sensory nerve endings in the epidermis, dermal-epidermal junction, and other sites. Mediators that have been identified as potential peripheral or central contributors to pruritus include histamine, proteases, cathepsins, gastrin releasing peptide, opioids, substance P, nerve growth factor, interleukins, and prostaglandins and their respective receptors [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/9-11\" class=\"abstract_t\">9-11</a>]. Of these, the identification of Mas-related G protein-coupled receptors (an itch-specific population of neurons) represents a major advance in understanding chronic itch. These receptors are key for transmission of nonhistaminergic itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/12\" class=\"abstract_t\">12</a>].</p><p>The itch-transmitting primary afferent C neurons synapse with secondary transmission neurons that cross over to the contralateral spinothalamic tract and ascend to the thalamus. The itch stimulus then travels to the cerebral cortex, where multiple sites in the brain are activated, including those involved in sensory function, motor function, and emotion [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/6,13,14\" class=\"abstract_t\">6,13,14</a>]. This suggests that there is no single area primarily responsible for processing this stimulus, a factor that may contribute to the multidimensional psychological and physical aspects of pruritus.</p><p>Both scratching and rubbing skin inhibit the sensation of pruritus by stimulating inhibitory local circuits in the spinal cord and brain [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/15,16\" class=\"abstract_t\">15,16</a>]; scratching also stimulates pain receptors, which inhibits the sensation of itch. The inhibitory interneurons can be activated by both peripheral and central stimuli, and they release endogenous opiates [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/5\" class=\"abstract_t\">5</a>]. Additionally, central sensitization for itching may occur in patients with chronic pruritus such that noxious stimuli are perceived as itch rather than pain [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/13,17\" class=\"abstract_t\">13,17</a>].</p><p class=\"headingAnchor\" id=\"H690774\"><span class=\"h1\">CLASSIFICATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute pruritus is defined as pruritus lasting less than six weeks; the term chronic pruritus refers to symptoms of longer duration [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/18,19\" class=\"abstract_t\">18,19</a>]. Chronic pruritus is often difficult to manage and can be debilitating; therapies that provide transient relief usually do not address the underlying causes of chronic pruritus.</p><p>A two tier classification system for pruritus has been proposed by a panel of experts from the International Forum for the Study of Itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/18\" class=\"abstract_t\">18</a>]. The first tier allows the classification of pruritus when the diagnosis is unknown. The clinical presentation of pruritus is divided into three groups:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Group I </strong>&ndash; Pruritus on diseased (inflamed) skin</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Group II </strong>&ndash; Pruritus on non-diseased (noninflamed skin)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Group III </strong>&ndash; Pruritus presenting with severe chronic secondary scratch lesions</p><p/><p>A skin biopsy may be useful for the evaluation of patients in Group I, as it may assist in identifying a primary skin disease. Skin biopsy generally is not useful in patients in the last two groups. </p><p>When the origin of pruritus is known, pruritus can be divided into the following categories:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dermatologic </strong>&ndash; This group contains pruritus resulting from primary skin disorders. Examples include xerosis, atopic dermatitis, psoriasis, cutaneous infections, and cutaneous T-cell lymphoma. This group accounts for almost all disorders in group I.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Systemic </strong>&ndash; Systemic causes of pruritus consist of disorders that affect other organ systems, such as chronic renal failure, liver disease, hematologic or lymphoproliferative disorders, and malignancy. Drug induced pruritus is also included in this category.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Neurologic </strong>&ndash; This group includes pruritus related to disorders of the peripheral or central nervous system. Examples include notalgia paresthetica, brachioradial pruritus, and multiple sclerosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Psychogenic </strong>&ndash; Examples of psychiatric disorders in which patients may complain of pruritus include depression, anxiety, psychogenic excoriation, and delusional infestation (also called delusional parasitosis).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Mixed </strong>&ndash; Pruritus attributed to more than one cause is placed in this category.</p><p/><p class=\"headingAnchor\" id=\"H690781\"><span class=\"h1\">ETIOLOGY</span></p><p class=\"headingAnchor\" id=\"H690788\"><span class=\"h2\">Dermatologic disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Numerous dermatologic disorders present with pruritus, most of which are characterized by the presence of visible skin inflammation. Examples of some of the disorders that may present with pruritus are provided below.</p><p class=\"headingAnchor\" id=\"H690795\"><span class=\"h3\">Xerosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In older adults, the most common cause of pruritus in the absence of an obvious skin eruption is xerosis, or dry skin [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/20\" class=\"abstract_t\">20</a>]. Most commonly seen in the winter, it is characterized by itching in areas of dry, scaly skin (<a href=\"image.htm?imageKey=DERM%2F67366\" class=\"graphic graphic_picture graphicRef67366 \">picture 1</a>). Symptoms often occur on the lower extremities. Severe xerosis may also precipitate the development of pruritic eczematous dermatitis.</p><p>Factors associated with xerosis include advanced age, frequent bathing, and ambient high temperatures with relatively low humidity, such as the environment produced by home heating in the winter [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/21\" class=\"abstract_t\">21</a>]. The cornerstone of therapy is maintaining adequate skin moisture with topical emollients. (See <a href=\"topic.htm?path=pruritus-overview-of-management#H8354494\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;, section on 'Xerosis (dry skin)'</a>.)</p><p class=\"headingAnchor\" id=\"H690802\"><span class=\"h3\">Atopic dermatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus is the hallmark symptom of atopic dermatitis and has a significant impact on sleep and quality of life [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/22\" class=\"abstract_t\">22</a>]. Alloknesis, a phenomenon in which a normally innocuous stimulus induces itch, is a prominent feature in this disorder [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/23\" class=\"abstract_t\">23</a>]. Sweating, sudden changes in temperature, clothing changes, and direct contact with wool can lead to intense pruritus. A vicious itch-scratch cycle, in which injury to the skin from scratching stimulates pruritus, can also occur in patients with atopic dermatitis. </p><p>The diagnosis of atopic dermatitis is predominantly clinical (<a href=\"image.htm?imageKey=PC%2F57187\" class=\"graphic graphic_table graphicRef57187 \">table 2</a>). Pruritus, chronic and recurring dermatitis, a positive family history of allergic disease, and an early age of onset of symptoms suggest the diagnosis (<a href=\"image.htm?imageKey=PC%2F52163\" class=\"graphic graphic_picture graphicRef52163 \">picture 2</a>). Other physical findings that may occur in association with atopic dermatitis include xerosis, infraorbital skin folds (Dennie-Morgan lines), periorbital darkening, hyperlinear palms (accentuation of fine palmar skin lines), keratosis pilaris (follicular accentuation that is usually present on the extensor surfaces of the upper arms), and infra-auricle lines and fissures. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690809\"><span class=\"h3\">Contact dermatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Contact dermatitis refers to any dermatitis arising from direct skin exposure to a substance. The dermatitis may be allergic or irritant-induced. In allergic contact dermatitis (<a href=\"image.htm?imageKey=PC%2F71913\" class=\"graphic graphic_picture graphicRef71913 \">picture 3</a>), the trigger induces an immune response, while in irritant contact dermatitis (<a href=\"image.htm?imageKey=PC%2F71834\" class=\"graphic graphic_picture graphicRef71834 \">picture 4</a>), the trigger itself directly damages the skin. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of allergic contact dermatitis&quot;</a> and <a href=\"topic.htm?path=irritant-contact-dermatitis-in-adults\" class=\"medical medical_review\">&quot;Irritant contact dermatitis in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690816\"><span class=\"h3\">Urticaria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Urticaria, or hives, is a common disorder that affects up to 25 percent of the population at some point during the course of life [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/24\" class=\"abstract_t\">24</a>]. The usual urticarial lesion is an intensely pruritic, circumscribed, raised, and erythematous eruption with central pallor. Individual lesions may enlarge or coalesce with other lesions, and typically disappear over a few hours (<a href=\"image.htm?imageKey=PC%2F72519%7EID%2F81678\" class=\"graphic graphic_picture graphicRef72519 graphicRef81678 \">picture 5A-B</a>). </p><p>Acute urticaria may be allergic in nature, while chronic urticaria (ie, regular outbreaks of hives occurring for more than six weeks) is rarely caused by allergy to an external substance [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/25\" class=\"abstract_t\">25</a>]. Urticaria may also occur in the setting of multiple systemic disorders. (See <a href=\"topic.htm?path=new-onset-urticaria#H30\" class=\"medical medical_review\">&quot;New-onset urticaria&quot;, section on 'Systemic disorders that may include urticaria'</a>.)</p><p class=\"headingAnchor\" id=\"H690823\"><span class=\"h3\">Dermatophytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Superficial fungal infections due to dermatophytes (tinea infections) are common causes of localized pruritus. Tinea cruris typically presents with bilateral, half-moon shaped lesions starting in the inguinal folds and extending to the upper thighs (<a href=\"image.htm?imageKey=PC%2F56684\" class=\"graphic graphic_picture graphicRef56684 \">picture 6</a>). Central clearing is often apparent. Predisposing factors include warm temperatures, prolonged exposure to moisture, obesity, and tight-fitting clothing [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. Tinea pedis (athlete's foot) presents as a whitish maceration between the digits of the feet, or as dry, scaly skin or localized blisters (<a href=\"image.htm?imageKey=DERM%2F76067%7EPC%2F54214\" class=\"graphic graphic_picture graphicRef76067 graphicRef54214 \">picture 7A-B</a>). Tinea capitis, which most commonly occurs in children, can be associated with scalp pruritus (<a href=\"image.htm?imageKey=DERM%2F86628\" class=\"graphic graphic_picture graphicRef86628 \">picture 8</a>). (See <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690830\"><span class=\"h3\">Lichen simplex chronicus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lichen simplex chronicus is not a primary skin disorder. Rather, the lichenified plaques (thickened skin with accentuated skin markings) and excoriations of lichen simplex chronicus result from excessive scratching (<a href=\"image.htm?imageKey=DERM%2F73843\" class=\"graphic graphic_picture graphicRef73843 \">picture 9</a>). Lesions only occur in skin sites accessible to scratching. </p><p>Patients typically complain of intense pruritus in the affected areas. Common sites of involvement include the scalp, neck, extensor forearms, scrotum, and lower legs. </p><p>Lichen simplex chronicus is commonly noted in adult forms of atopic dermatitis and can also be noted in patients with neuropathic pruritus, such as in brachioradial pruritus and diabetic neuropathy. Psychological factors, such as depression, also may contribute to lichen simplex chronicus [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/27\" class=\"abstract_t\">27</a>]. Breaking the cycle of scratching is the central goal of treatment. (See <a href=\"topic.htm?path=pruritus-overview-of-management\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690837\"><span class=\"h3\">Psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus is reported in approximately 80 percent of patients with psoriasis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/28\" class=\"abstract_t\">28</a>]. There tends to be a cyclical quality to the symptoms, with the majority of pruritus occurring at night. Furthermore, pruritus is not restricted to the area of the psoriatic plaque, often being generalized and poorly responsive to antipruritics [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/29\" class=\"abstract_t\">29</a>]. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of psoriasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690844\"><span class=\"h3\">Scabies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Scabies (from the Latin for &quot;scratching&quot;) is caused by the mite <em>Sarcoptes scabiei</em>, which lays its eggs in the epidermal layer of human skin. The outstanding clinical feature of scabies is intense itching. It is often severe and usually worse in the evening and night. (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p>The essential lesion is a small, erythematous, nondescript papule, often excoriated and tipped with hemorrhagic crusts (<a href=\"image.htm?imageKey=PC%2F51161%7EPC%2F53894\" class=\"graphic graphic_picture graphicRef51161 graphicRef53894 \">picture 10A-B</a>). It is not a dramatic lesion and is not always easy to see. More striking, when present, is the burrow. Pathognomonic when correctly identified, the burrow is a thin, grayish, reddish, or brownish line some 2 to 15 mm long (<a href=\"image.htm?imageKey=DERM%2F53715\" class=\"graphic graphic_picture graphicRef53715 \">picture 11</a>). Burrows are often absent, however, or obscured by eczematization or secondary infection. </p><p>Lesions are most common in intertriginous areas such as the neck, axillae, genitals, and finger webs. Involvement of the face and scalp may occur in young children, but is uncommon in adults.</p><p>Pruritus in scabies is due to a delayed hypersensitivity response to the mite proteins. Itch can continue for several weeks after the mites are eradicated [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/30\" class=\"abstract_t\">30</a>]. </p><p class=\"headingAnchor\" id=\"H690851\"><span class=\"h3\">Pediculosis corporis and pubis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Also known as &quot;body lice&quot; and &quot;pubic lice,&quot; these infestations are marked by itching caused by a delayed hypersensitivity reaction to the saliva of the louse (<a href=\"image.htm?imageKey=DERM%2F73592%7EPC%2F55191\" class=\"graphic graphic_picture graphicRef73592 graphicRef55191 \">picture 12A-B</a>) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. Diagnosis is made by appearance, although a magnifying lens is often necessary in order to see the eggs or lice. Pediculosis corporis typically occurs in patients with poor hygienic practices, unlike pediculosis pubis, which is primarily a sexually transmitted disease [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=pediculosis-corporis\" class=\"medical medical_review\">&quot;Pediculosis corporis&quot;</a> and <a href=\"topic.htm?path=pediculosis-pubis-and-pediculosis-ciliaris\" class=\"medical medical_review\">&quot;Pediculosis pubis and pediculosis ciliaris&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1120095\"><span class=\"h3\">Bullous pemphigoid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus is a characteristic feature of bullous pemphigoid, an autoimmune mucocutaneous blistering disorder that primary occurs in older adults. Although most patients with bullous pemphigoid develop eczematous or urticarial plaques with or without bullae, a subset of patients present with pruritus in the absence of primary skin lesions. In a series of 15 patients with pruritus without blisters and immunopathologic findings consistent with bullous pemphigoid (pruritic nonbullous pemphigoid), 3 had only linear excoriations from scratching and lacked visible evidence of pruritic skin lesions [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690858\"><span class=\"h3\">Allergies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the absence of urticaria, atopic dermatitis, or contact dermatitis, allergies are a rare cause of pruritus (apart from localized pruritus of mucous membranes). </p><p class=\"headingAnchor\" id=\"H690865\"><span class=\"h2\">Systemic disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus caused by systemic disease typically presents without a primary skin eruption. Secondary skin lesions related to scratching and rubbing, such as lichenified plaques, excoriations, and prurigo nodules, are often present. There are a number of systemic diseases, including malignancy, that should be considered when a patient presents with generalized pruritus without any dermatologic manifestations (<a href=\"image.htm?imageKey=DERM%2F74678\" class=\"graphic graphic_table graphicRef74678 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H690872\"><span class=\"h3\">Renal disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Uremic pruritus remains one of the most frustrating, common, and potentially disabling symptoms in patients with end-stage renal disease. The disorder is common among dialysis patients. Patients typically complain of pruritus, which is often generalized but may be most prominent on the back [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/32-34\" class=\"abstract_t\">32-34</a>]. Many patients experience a worsening of symptoms in the evening and night. Pruritus may also be exacerbated during and at the conclusion of dialysis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/32,35\" class=\"abstract_t\">32,35</a>]. (See <a href=\"topic.htm?path=uremic-pruritus\" class=\"medical medical_review\">&quot;Uremic pruritus&quot;</a>.)</p><p>A number of factors may contribute to uremic pruritus in individual patients, but a specific general etiology has not been identified. Pruritus in renal disease is often very difficult to treat and may be associated with a poor prognosis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/36\" class=\"abstract_t\">36</a>]. </p><p class=\"headingAnchor\" id=\"H690879\"><span class=\"h3\">Cholestasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cholestatic pruritus, which occurs due to the impaired secretion of bile, is a common symptom seen in certain forms of liver disease. It is typically generalized and often begins with an acral distribution involving the palms and soles, areas that are uncommon sites for pruritus in other systemic diseases. Symptoms later become more generalized [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/37\" class=\"abstract_t\">37</a>]. Associated conditions include: primary biliary cirrhosis, pruritus gravidarum (see <a href=\"topic.htm?path=intrahepatic-cholestasis-of-pregnancy\" class=\"medical medical_review\">&quot;Intrahepatic cholestasis of pregnancy&quot;</a>), sclerosing cholangitis, viral hepatitis, drug-induced cholestasis, as well as cases of obstructive jaundice. Pruritus is the presenting symptom of primary biliary cirrhosis in 50 percent of patients and occurs at some point in almost 100 percent of patients [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-primary-biliary-cholangitis-primary-biliary-cirrhosis\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and prognosis of primary biliary cholangitis (primary biliary cirrhosis)&quot;</a>.)</p><p>The mechanism of cholestatic pruritus has not been clearly elucidated. Patients with cholestatic pruritus have elevated plasma opioid levels, which conceivably could contribute to itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/37\" class=\"abstract_t\">37</a>]. In addition, the enzyme autotaxin and its substrate lysophosphatidic acid have been proposed as potential mediators in cholestatic itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/37,39\" class=\"abstract_t\">37,39</a>]. (See <a href=\"topic.htm?path=pruritus-associated-with-cholestasis\" class=\"medical medical_review\">&quot;Pruritus associated with cholestasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690886\"><span class=\"h3\">Malignancy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While generalized pruritus may be the presenting sign of hematologic malignancies, the association is not as strong in solid tumors. Pruritus occasionally presents years before the malignancy becomes clinically detectable. Pruritus may also occur as a feature of paraneoplastic skin diseases, such as eruptive seborrheic keratosis, malignant acanthosis nigricans, dermatomyositis, erythroderma, and transient acantholytic dermatosis (Grover disease) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/40,41\" class=\"abstract_t\">40,41</a>]. (See <a href=\"topic.htm?path=cutaneous-manifestations-of-internal-malignancy#H3208461\" class=\"medical medical_review\">&quot;Cutaneous manifestations of internal malignancy&quot;, section on 'Sign of Leser-Tr&eacute;lat'</a> and <a href=\"topic.htm?path=cutaneous-manifestations-of-internal-malignancy#H9\" class=\"medical medical_review\">&quot;Cutaneous manifestations of internal malignancy&quot;, section on 'Acanthosis nigricans'</a> and <a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations of dermatomyositis and polymyositis in adults&quot;</a> and <a href=\"topic.htm?path=grovers-disease-transient-and-persistent-acantholytic-dermatosis\" class=\"medical medical_review\">&quot;Grover's disease (transient and persistent acantholytic dermatosis)&quot;</a>.)</p><p>The most common malignancies associated with pruritus include Hodgkin lymphoma, non-Hodgkin lymphoma, mycosis fungoides, polycythemia vera, leukemias, plasma cell dyscrasias, and gastric carcinoid tumors. (See <a href=\"topic.htm?path=cutaneous-manifestations-of-internal-malignancy\" class=\"medical medical_review\">&quot;Cutaneous manifestations of internal malignancy&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hodgkin lymphoma </strong>&ndash; Itching as a primary symptom is commonly seen in patients with Hodgkin lymphoma, developing in approximately 30 percent of cases [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/42\" class=\"abstract_t\">42</a>]. In some patients, pruritus precedes the clinical presentation of lymphoma by up to five years and therefore can be regarded as a paraneoplastic sign [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38,40\" class=\"abstract_t\">38,40</a>]. Itching is often located on the lower extremities and is occasionally accompanied with ichthyosiform skin changes. Pruritus related to Hodgkin lymphoma is often more severe in older patients and patients with more advanced disease. Symptoms may be aggravated at night [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/37,40\" class=\"abstract_t\">37,40</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Polycythemia vera </strong>&ndash; Aquagenic pruritus (water-induced itching) may occur in up to two-thirds of patients with polycythemia vera [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/43\" class=\"abstract_t\">43</a>]. Patients frequently complain of intractable itching within minutes after contact with water. Alternatively, stinging, tingling, or burning sensations occur. The chest, back, medial upper arms, and anterior legs are common sites of involvement [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/43\" class=\"abstract_t\">43</a>]. Aquagenic pruritus may precede a diagnosis of polycythemia vera by several years or more. The condition has also been associated with other diseases including myelodysplastic disorders and T cell lymphomas. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-polycythemia-vera#H6\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of polycythemia vera&quot;, section on 'Pruritus'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Mycosis fungoides </strong>&ndash; Pruritus is a frequent manifestation of mycosis fungoides (cutaneous T cell lymphoma), although it is typically not present in the absence of cutaneous findings [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/44\" class=\"abstract_t\">44</a>]. The erythrodermic form of mycosis fungoides and S&eacute;zary syndrome are extremely pruritic. Folliculotropic mycosis fungoides has been reported to be extremely pruritic regardless of the stage of the disease. There are case reports of pruritus preceding the onset of skin findings by several years [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other hematologic malignancies </strong>&ndash; Patients with non-Hodgkin lymphoma may present with pruritus, but there are limited epidemiologic data on the prevalence of this symptom. Other hematologic malignancies linked to chronic pruritus include leukemia, most commonly chronic lymphocytic leukemia, as well as multiple myeloma and mastocytosis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38,40\" class=\"abstract_t\">38,40</a>]. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of non-Hodgkin lymphoma&quot;</a> and <a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia&quot;</a> and <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations&quot;</a> and <a href=\"topic.htm?path=clinical-features-laboratory-manifestations-and-diagnosis-of-multiple-myeloma\" class=\"medical medical_review\">&quot;Clinical features, laboratory manifestations, and diagnosis of multiple myeloma&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Gastric carcinoid </strong>&ndash; In contrast to the usually nonpruritic intermittent cutaneous flushing associated with intestinal carcinoids, the intermittent &quot;histamine&quot; flush associated with atypical gastric carcinoids tends to be pruritic. (See <a href=\"topic.htm?path=clinical-features-of-the-carcinoid-syndrome#H16\" class=\"medical medical_review\">&quot;Clinical features of the carcinoid syndrome&quot;, section on 'Gastric NET variant syndrome'</a>.)</p><p/><p>Patients who do not have evidence of malignancy at the time of a diagnosis of pruritus may have a slightly increased risk for a future diagnosis of malignancy [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/46,47\" class=\"abstract_t\">46,47</a>]. As an example, in a population-based cohort study that used electronic medical records of 8744 patients with chronic pruritus and 31,580 patients without chronic pruritus from the United Kingdom to compare the five-year risk for new malignancy in these populations, patients with chronic pruritus demonstrated increased risk for hematologic malignancy (adjusted hazard ratio 2.02, 95% CI 1.48-2.75) and bile duct carcinoma (adjusted hazard ratio 3.73, 95% CI 1.55-8.97), but not for other types of cancer [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/46\" class=\"abstract_t\">46</a>]. A nationwide Danish cohort study that examined the relationship between a pruritus diagnosis (duration unspecified) and subsequent cancer found increased risk for hematologic malignancies as well as several other types of cancer [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H690893\"><span class=\"h3\">Thyroid disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Generalized pruritus is seen commonly in patients with thyrotoxicosis, particularly in cases of Graves' disease [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38,42\" class=\"abstract_t\">38,42</a>]. (See <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-hyperthyroidism-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of hyperthyroidism in adults&quot;</a>.) Possible mechanisms include reduction of the itch threshold mediated by vasodilation, as well as activation of kinin pathways secondary to an increased metabolic rate. Hypothyroidism is less frequently associated with itch and is associated with skin xerosis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-of-hypothyroidism\" class=\"medical medical_review\">&quot;Clinical manifestations of hypothyroidism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690900\"><span class=\"h3\">Diabetes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Generalized itching does not appear to occur at increased frequency in diabetic patients [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/48\" class=\"abstract_t\">48</a>]. However, pruritus due to other disorders in diabetic patients, including dermatophyte infections, xerosis, diabetic neuropathy, or Candida infections (such as may occur in the anogenital region), may occur [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38\" class=\"abstract_t\">38</a>]. In particular, diabetic neuropathy may account for otherwise unexplained pruritus localized to the lower extremities, scalp, or trunk [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/49,50\" class=\"abstract_t\">49,50</a>]. Pruritus vulvae has been associated with poorly controlled diabetes. (See <a href=\"topic.htm?path=vulvar-dermatitis\" class=\"medical medical_review\">&quot;Vulvar dermatitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690907\"><span class=\"h3\">HIV</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus is a common symptom in patients with human immunodeficiency virus (HIV) infection that can have a significant negative effect on quality of life [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/51,52\" class=\"abstract_t\">51,52</a>]. A study of 303 HIV-infected patients in Spain found a point prevalence of pruritus of 31 percent [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/51\" class=\"abstract_t\">51</a>]. In addition, chronic pruritus was reported by 45 percent of 201 HIV-infected patients in a study in the United States [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/52\" class=\"abstract_t\">52</a>]. The majority of patients in both studies were receiving antiretroviral therapy. </p><p>Pruritus in the setting of HIV-infection may occur as a result of primary skin disorders that are common in human immunodeficiency virus (HIV)&ndash;infected individuals (eg, xerosis, seborrheic dermatitis, and dermatophyte infections). It may also be associated with systemic disease in patients with HIV infection (eg, lymphoma, chronic renal disease, or hepatic disease) or may present as a manifestation of early HIV infection [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/53\" class=\"abstract_t\">53</a>].</p><p>Eosinophilic folliculitis is an intensely pruritic condition associated with advanced HIV disease. It is characterized by a perifollicular papular eruption that involves the upper trunk, limbs, and face (<a href=\"image.htm?imageKey=DERM%2F87125\" class=\"graphic graphic_picture graphicRef87125 \">picture 13</a>) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/54\" class=\"abstract_t\">54</a>]. (See <a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">&quot;HIV-associated eosinophilic folliculitis&quot;</a>.)</p><p>Examples of other causes of itch in HIV-infected individuals are eczema, insect bite hypersensitivity reactions, pruritic papular eruption of HIV infection, psoriasis, scabies, and itch associated with lichenoid dermatitis. </p><p class=\"headingAnchor\" id=\"H693620\"><span class=\"h3\">Connective tissue diseases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Itch is a common symptom of dermatomyositis, systemic sclerosis (scleroderma), and primary Sj&ouml;gren's syndrome (P-SS) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/55-59\" class=\"abstract_t\">55-59</a>]. The pathophysiology of chronic itch in connective tissue disorders is not well understood; however, P-SS is highly associated with skin xerosis. Patients with dermatomyositis frequently experience intense pruritus that impairs their ability to sleep and affects their quality of life. Most often patients with cutaneous lupus erythematosus have little or no itching. Therefore, the presence of severe pruritus in a patient with presumed lupus erythematosus should result in a careful reassessment of the diagnosis. (See <a href=\"topic.htm?path=initial-management-of-cutaneous-dermatomyositis-in-adults#H28087755\" class=\"medical medical_review\">&quot;Initial management of cutaneous dermatomyositis in adults&quot;, section on 'Impact on quality of life'</a> and <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-sclerosis-scleroderma-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690914\"><span class=\"h3\">Medication</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The mechanisms through which drugs induce itch vary. As examples, pruritus may result from drug-induced skin dryness, such as may occur with systemic retinoid therapy, or as an associated feature of drug-induced phototoxicity, such as may follow <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> therapy. </p><p>In addition, pruritus without an associated skin eruption is a side effect of numerous medications (<a href=\"image.htm?imageKey=DERM%2F87630\" class=\"graphic graphic_table graphicRef87630 \">table 3</a>). Pruritus frequently accompanies the use of opiates, particularly when intrathecally or epidurally administered, with a reported incidence between 30 and 100 percent [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/60\" class=\"abstract_t\">60</a>]. Pruritus also has been reported as a side effect of a number of molecularly targeted anti-neoplastic agents, including epidermal growth factor inhibitors, tyrosine kinase inhibitors, BRAF inhibitors, and MEK inhibitors [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/61-64\" class=\"abstract_t\">61-64</a>]. Drug-induced cholestasis may also induce pruritus [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/65,66\" class=\"abstract_t\">65,66</a>]. (See <a href=\"#H690879\" class=\"local\">'Cholestasis'</a> above and <a href=\"topic.htm?path=pruritus-associated-with-cholestasis\" class=\"medical medical_review\">&quot;Pruritus associated with cholestasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690921\"><span class=\"h2\">Neurologic disorders (neuropathic itch)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurologic dysfunction results in the development of itch in multiple disorders, including brachioradial pruritus, notalgia paresthetica, postherpetic neuralgia, and other disorders.</p><p class=\"headingAnchor\" id=\"H690928\"><span class=\"h3\">Brachioradial pruritus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brachioradial pruritus presents with localized pruritus involving the proximal dorsolateral forearm. Symptoms may be intermittent, unilateral or bilateral, and in some cases may extend to the upper arm, shoulder, neck, or upper trunk [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/67\" class=\"abstract_t\">67</a>]. Symptomatic relief often occurs with application of ice to the affected area (the &quot;ice-pack sign&quot;), a finding that may assist with diagnosis [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/68,69\" class=\"abstract_t\">68,69</a>]. </p><p>The pathogenesis of brachioradial pruritus is not well understood. Current theories suggest cervical nerve root impingement at the levels of C5 to C8 as a predisposing factor and solar radiation as an exacerbating factor [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/70-72\" class=\"abstract_t\">70-72</a>]. Rarely, brachioradial pruritus is associated with spinal tumors; in such cases, motor or neurologic deficits usually are present [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/73,74\" class=\"abstract_t\">73,74</a>]. </p><p>The relationship between brachioradial pruritus and cervical spine disorders was evaluated in a retrospective study of 111 patients with brachioradial pruritus [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/69\" class=\"abstract_t\">69</a>]. Cervical spine abnormalities (primarily degenerative joint disease) were detected in 42 of 45 patients (93 percent) who underwent radiologic imaging of the cervical spine. The relevance of these findings was unclear given that only 8 of 31 patients (26 percent) referred to neurologists for evaluation were thought to have radiculopathy or peripheral neuropathy as a contributor to their symptoms.</p><p>Support for sun exposure as a contributing factor stems from the observation that affected individuals are often fair-skinned, middle-aged adults who live in sunny climates and frequently engage in outdoor leisure activities. Moreover, the condition frequently worsens during the summer months [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/69\" class=\"abstract_t\">69</a>]. </p><p>Additional study is necessary to determine the pathogenic mechanism of brachioradial pruritus. It is unclear whether routine radiologic evaluation of the cervical spine is of value. We typically reserve radiologic imaging and referral to neurology for patients with other neurological symptoms. Radiologic imaging also may be performed for further evaluation in treatment-refractory cases [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/69\" class=\"abstract_t\">69</a>]. The treatment of brachioradial pruritus is reviewed separately. (See <a href=\"topic.htm?path=pruritus-overview-of-management#H8354522\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;, section on 'Brachioradial pruritus'</a>.)</p><p class=\"headingAnchor\" id=\"H690935\"><span class=\"h3\">Notalgia paresthetica</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Like brachioradial pruritus, notalgia paresthetica is characterized by localized pruritus and appears to be of neurologic origin. The current view on etiology is that the itch is due to nerve entrapment of the posterior rami of spinal nerves that arise from T2 to T6 [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/75\" class=\"abstract_t\">75</a>]. </p><p>The symptoms are unilateral and involve skin medial to the scapular border on the mid or upper back. Cutaneous changes secondary to scratching or rubbing the skin (such as hyperpigmentation) are the only visible findings (<a href=\"image.htm?imageKey=DERM%2F56937\" class=\"graphic graphic_picture graphicRef56937 \">picture 14</a>). Secondary amyloid deposition may be detected in skin biopsies. (See <a href=\"topic.htm?path=pruritus-overview-of-management#H8354529\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;, section on 'Notalgia paresthetica'</a>.)</p><p class=\"headingAnchor\" id=\"H690942\"><span class=\"h3\">Postherpetic neuralgia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Between 30 and 58 percent of patients with postherpetic neuralgia experience pruritus at the site of herpes zoster [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/76,77\" class=\"abstract_t\">76,77</a>]. Symptoms may be most likely to occur in following eruptions on the head, face, or neck [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/76\" class=\"abstract_t\">76</a>]. Pruritus also may occur in association with acute herpes zoster. (See <a href=\"topic.htm?path=pruritus-overview-of-management#H8354536\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;, section on 'Postherpetic itch'</a>.)</p><p class=\"headingAnchor\" id=\"H690949\"><span class=\"h3\">Multiple sclerosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infrequently, patients with multiple sclerosis experience recurrent and severe episodes of generalized pruritus [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/78\" class=\"abstract_t\">78</a>]. Symptoms have been attributed to activation of artificial synapses in areas of demyelination [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"topic.htm?path=clinical-features-of-multiple-sclerosis-in-adults#H3922656389\" class=\"medical medical_review\">&quot;Clinical features of multiple sclerosis in adults&quot;, section on 'Sensory symptoms'</a>.)</p><p class=\"headingAnchor\" id=\"H690956\"><span class=\"h3\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pruritus may be a symptom of small-fiber neuropathies (disorders of small nerve fibers associated with autonomic and sensory symptoms) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/79\" class=\"abstract_t\">79</a>]. Small-fiber neuropathies may be idiopathic or associated with other diseases (eg, diabetes, infection, autoimmune disorders, Fabry disease, etc). In addition, neuropathic itch can occur as a result cerebrovascular accidents, trigeminal trophic syndrome [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/80\" class=\"abstract_t\">80</a>], or Creutzfeldt-Jakob disease [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/81,82\" class=\"abstract_t\">81,82</a>]. </p><p class=\"headingAnchor\" id=\"H690963\"><span class=\"h2\">Psychogenic itch</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>General or localized pruritus can occur in the setting of psychiatric illnesses or somatoform disorders. In a study of 100 psychiatric inpatients, the prevalence of generalized pruritus was 42 percent [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/83\" class=\"abstract_t\">83</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Psychogenic excoriation </strong>&ndash; Psychogenic excoriation (aka neurotic excoriation) is a disorder in which individuals excessively pick and scratch normal skin. Affected patients typically complain of significant pruritus. On physical exam, scattered, linear, crusted lesions may be present anywhere on the body within reach of the patient, although they are most often confined to the extremities [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=skin-picking-excoriation-disorder-and-related-disorders\" class=\"medical medical_review\">&quot;Skin picking (excoriation) disorder and related disorders&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Psychologic stress may be associated with the development of symptoms [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/84\" class=\"abstract_t\">84</a>]. In one study of 68 patients with psychogenic excoriation, 90 percent described a conflict or stressor preceding the onset of the condition [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/85\" class=\"abstract_t\">85</a>]. Increased rates of psychiatric diseases, particularly mood and anxiety disorders, have also been identified in patients with this disorder [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/86\" class=\"abstract_t\">86</a>]. As an example, a case-control study (n = 100) found that the prevalence of self-reported depression or bipolar disorder was significantly greater among patients with psychogenic excoriation than among controls (42 versus 18 percent and 12 versus 0 percent, respectively) [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/87\" class=\"abstract_t\">87</a>]. </p><p/><p class=\"bulletIndent1\">Delusional infestation is a separate psychiatric disorder characterized by the patient's false belief that he or she is suffering from a parasitic infection. Patients often complain of pruritus. Delusional infestation is discussed in greater detail separately. (See <a href=\"topic.htm?path=delusional-infestation-epidemiology-clinical-presentation-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Delusional infestation: Epidemiology, clinical presentation, assessment and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Due to the increased prevalence of psychopathology among patients with otherwise unexplained pruritus, clinicians should consider the possibility of an underlying psychiatric disorder in such patients.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Drug use </strong>&ndash; Individuals with substance use disorders involving opioids, cocaine, or amphetamines often complain of itch and scratching. (See <a href=\"topic.htm?path=opioid-use-disorder-epidemiology-pharmacology-clinical-manifestations-course-screening-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Opioid use disorder: Epidemiology, pharmacology, clinical manifestations, course, screening, assessment, and diagnosis&quot;</a> and <a href=\"topic.htm?path=cocaine-use-disorder-in-adults-epidemiology-pharmacology-clinical-manifestations-medical-consequences-and-diagnosis\" class=\"medical medical_review\">&quot;Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis&quot;</a> and <a href=\"topic.htm?path=methamphetamine-use-disorder-epidemiology-clinical-manifestations-course-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Methamphetamine use disorder: Epidemiology, clinical manifestations, course, assessment, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other factors </strong>&ndash; Psychologic factors might affect the severity of pruritus in individuals with pruritus unrelated to a psychological disorder. A study that explored the impact of emotional states on pruritus found that sensitivity to pruritus was greater during exposure to a film that was intended to elicit negative emotions than to a film that was intended to elicit positive emotions [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/88\" class=\"abstract_t\">88</a>]. Further studies are necessary to clarify the impact of emotional states on pruritus.</p><p/><p class=\"bulletIndent1\">Itching, like yawning, may be contagious, causing people to feel an urge to scratch after they see another person scratching. This seems more common in patients who suffer from chronic itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/89,90\" class=\"abstract_t\">89,90</a>].</p><p/><p class=\"headingAnchor\" id=\"H690970\"><span class=\"h2\">Other associations</span></p><p class=\"headingAnchor\" id=\"H690977\"><span class=\"h3\">Advanced age</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Idiopathic itch in older adults, sometimes inappropriately referred to as senile pruritus, is common and presents a diagnostic and therapeutic challenge [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/91\" class=\"abstract_t\">91</a>]. It is important to assess and treat itch, particularly nocturnal itch, due to the significant impact on quality of life and on sleep in older adults.</p><p>Dry skin (xerosis) is probably the most common cause of pruritus in older adult individuals; other causes for pruritus are inflammatory skin diseases, immunosenescence (age-associated changes in the immune system), degenerative spinal cord and neuropathic changes, as well as underlying systemic disorders, such as cholestasis, renal failure, and iron deficiency anemia. In addition, epidemics of scabies are potential causes of pruritus in crowded nursing homes. Age-related changes in nerve fibers and loss of input from pain fibers leading to central disinhibition of itch [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/92\" class=\"abstract_t\">92</a>] may play a role in otherwise unexplained pruritus. </p><p>A study of 302 geriatric patients in Mexican nursing homes and geriatric outpatient centers supports the high prevalence of chronic itch in the older adult population [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/93\" class=\"abstract_t\">93</a>]. Among the patients, 25 percent had chronic itch, among whom 69 percent had xerosis and 28 percent had itch-related dermatoses (eg, stasis dermatitis, psoriasis, allergic contact dermatitis, lichen simplex chronicus). Certain comorbidities were associated with the presence of chronic itch, including diabetes mellitus and chronic venous insufficiency.</p><p class=\"headingAnchor\" id=\"H88784958\"><span class=\"h3\">Sex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sex influences susceptibility to certain forms of pruritus. As an example, vulvar pruritus is a common symptom in females that can occur as a feature of a wide variety of cutaneous disorders [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/94\" class=\"abstract_t\">94</a>]. Vulvar pruritus in prepubertal females often is secondary to atopic dermatitis, irritant contact dermatitis, psoriasis, or lichen sclerosus, though other disorders, such as pinworms or streptococcal infection, also may cause this symptom in children. Women of reproductive age with vulvar pruritus are most likely to have vulvovaginal candidiasis, allergic or irritant contact dermatitis, lichen simplex chronicus, psoriasis, or lichen sclerosus. Postmenopausal women are particularly susceptible to vaginal pruritus due to atrophic vulvovaginitis, lichen sclerosus, irritant contact dermatitis, or vulvar squamous cell carcinoma. Pruritic disorders specific to pregnancy may also occur in women. Vulvar dermatoses and pruritic dermatoses of pregnancy are reviewed separately. (See <a href=\"topic.htm?path=overview-of-vulvovaginal-complaints-in-the-prepubertal-child\" class=\"medical medical_review\">&quot;Overview of vulvovaginal complaints in the prepubertal child&quot;</a> and <a href=\"topic.htm?path=vulvar-lesions-differential-diagnosis-based-on-morphology\" class=\"medical medical_review\">&quot;Vulvar lesions: Differential diagnosis based on morphology&quot;</a> and <a href=\"topic.htm?path=vulvar-dermatitis\" class=\"medical medical_review\">&quot;Vulvar dermatitis&quot;</a> and <a href=\"topic.htm?path=vulvar-lichen-sclerosus\" class=\"medical medical_review\">&quot;Vulvar lichen sclerosus&quot;</a> and <a href=\"topic.htm?path=vulvar-lichen-planus\" class=\"medical medical_review\">&quot;Vulvar lichen planus&quot;</a> and <a href=\"topic.htm?path=dermatoses-of-pregnancy\" class=\"medical medical_review\">&quot;Dermatoses of pregnancy&quot;</a>.)</p><p>The possibility of other sex or gender differences in pruritus was explored in a retrospective study of 568 women and 469 men with chronic pruritus (pruritus persisting for more than six weeks) who were evaluated in a specialized itch clinic in Germany [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/95\" class=\"abstract_t\">95</a>]. Statistically significant differences in the characteristics and morbidity of pruritus were detected. As examples, women were more likely to report sensations of stinging, warmth, or pain in association with itch, and men were more likely to have chronic pruritus resulting from dermatologic or systemic diseases. Additional studies are necessary to clarify the impact of sex on the characteristics and symptomatology of pruritus.</p><p class=\"headingAnchor\" id=\"H690984\"><span class=\"h3\">Burns and scars</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Burn scars are common in both children and adults and are associated with significant pruritus. A cohort study in 510 adults who were seen in two burn centers found an 87 percent prevalence rate of pruritus three months after a burn injury [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/96\" class=\"abstract_t\">96</a>]. (See <a href=\"topic.htm?path=treatment-of-minor-thermal-burns#H14\" class=\"medical medical_review\">&quot;Treatment of minor thermal burns&quot;, section on 'Pruritus'</a>.)</p><p>Keloids frequently are associated with itch at the periphery of the lesion. These findings probably result from entrapment of small nerve fibers [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/97\" class=\"abstract_t\">97</a>]. (See <a href=\"topic.htm?path=keloids-and-hypertrophic-scars\" class=\"medical medical_review\">&quot;Keloids and hypertrophic scars&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H690998\"><span class=\"h1\">EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A key component of patient evaluation is the determination of the presence or absence of primary skin lesions. The presence of primary skin lesions suggests a dermatologic disorder. In patients who present without skin lesions or with only secondary skin lesions (eg, excoriations, hyperpigmentation, or lichenification), the possibility of systemic, neurologic, or psychogenic causes of itch must be considered [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/19\" class=\"abstract_t\">19</a>]. Inquiries regarding the location (generalized or localized), temporal nature, and exacerbating and alleviating factors for pruritus can also offer clues for diagnosis. </p><p>An algorithm describing the approach to the evaluation of patients with pruritus is provided (<a href=\"image.htm?imageKey=DERM%2F80780\" class=\"graphic graphic_algorithm graphicRef80780 \">algorithm 1</a>).</p><p class=\"headingAnchor\" id=\"H691005\"><span class=\"h2\">Pruritus with primary skin lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of patients who present to outpatient medical clinics with pruritus will have an obvious primary skin disorder that explains their symptoms. The evaluation of such patients involves the identification of the cause of the skin eruption. A skin biopsy may be useful for diagnosis when the etiology is unclear. (See <a href=\"topic.htm?path=approach-to-dermatologic-diagnosis\" class=\"medical medical_review\">&quot;Approach to dermatologic diagnosis&quot;</a>.)</p><p>Occasionally, the skin findings in patients with primary skin disorders are subtle or simply consist of excoriations caused by excessive scratching [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/19\" class=\"abstract_t\">19</a>]. Xerosis may not be apparent unless the skin is inspected closely, when fine scaling and epidermal cracking may be visible [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/98\" class=\"abstract_t\">98</a>]. Scabies may not be obvious in patients in whom there are fewer than 10 lesions or who have only a few lesions on the genitalia [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. Inquiring about symptoms in other family members can be useful for the diagnosis of scabies, as pruritus affecting other household members strongly suggests this disorder. (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p>Finally, urticaria, by its transient nature, can often be missed. Examining the skin for dermographism is a helpful adjunct in identifying patients with pruritus related to dermatographism. Dermographism is present when stroking the skin firmly produces a linear urticarial itchy wheal within 30 minutes (<a href=\"image.htm?imageKey=ALLRG%2F50823\" class=\"graphic graphic_picture graphicRef50823 \">picture 15</a>). (See <a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">&quot;New-onset urticaria&quot;</a> and <a href=\"topic.htm?path=physical-urticarias#H10\" class=\"medical medical_review\">&quot;Physical urticarias&quot;, section on 'Dermographism'</a>.)</p><p class=\"headingAnchor\" id=\"H691012\"><span class=\"h2\">Generalized pruritus without primary skin lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A detailed patient history is particularly important in patients with generalized pruritus who lack primary skin lesions, as the differential diagnosis for this presentation is broad and includes disorders that are associated with significant morbidity [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/19\" class=\"abstract_t\">19</a>]. In addition to details regarding the nature of pruritus, the following components of the patient history may be useful for diagnosis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of thyroid disorders, liver disease, renal disease, HIV infection, or malignancy</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of constitutional symptoms (eg, fever, weight loss, night sweats)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medication history</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Travel history</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psychiatric and substance abuse history</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pruritus in other household members (suggests scabies without identifiable skin lesions)</p><p/><p>In the absence of primary skin findings, the physical examination should focus on looking for evidence of systemic disease. Findings of conjunctival pallor, thyromegaly, splenomegaly, or stigmata of liver disease should be sought out. Lymph nodes should be palpated for signs of lymphadenopathy.</p><p>Even in the absence of abnormal physical findings, the initial evaluation generally should not include an extensive laboratory investigation looking for the presence of systemic disease. Many authors advocate that such an evaluation be reserved for patients who have no evidence of skin disease on examination and who do not respond to a short course of antipruritic therapy [<a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"abstract_t\">26</a>]. We agree with this approach. (See <a href=\"topic.htm?path=pruritus-overview-of-management\" class=\"medical medical_review\">&quot;Pruritus: Overview of management&quot;</a>.) If the pruritus remains undiagnosed and the patient has not responded to initial therapy, subsequent evaluation should include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Complete blood count with differential</strong> to evaluate for evidence of malignancy, myeloproliferative disease, or iron deficiency</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Serum bilirubin, transaminases, and alkaline phosphatase</strong> to evaluate for evidence of liver disease</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Thyroid stimulating hormone</strong> to evaluate for evidence of a thyroid disorder </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>BUN and creatinine</strong> to evaluate for renal disease </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chest radiograph</strong> to evaluate for evidence of adenopathy</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>HIV antibody test</strong> in patients with historical risk factors for HIV infection</p><p/><p>Secondary laboratory considerations based upon patient history and suspicion for an underlying disorder include immunofluorescence studies and enzyme-linked immunosorbent assay to detect bullous pemphigoid, stool examination for ova and parasites, hepatitis B and C serologies, and serum protein electrophoresis and immunoelectrophoresis (if a plasma cell dyscrasia is suspected). </p><p class=\"headingAnchor\" id=\"H691019\"><span class=\"h2\">Localized pruritus without primary skin lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Localized pruritus in the absence of a skin eruption suggests the possibility of neuropathic or psychogenic itch. In particular, associated symptoms of burning sensations, pain, or sensory loss may occur in patients with neuropathic disease.</p><p class=\"headingAnchor\" id=\"H691026\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pruritus is a common disorder that may affect the skin, mucous membranes, and cornea. The pathogenic mechanisms that lead to the sensation of pruritus are not fully understood, but are thought to involve the transmission of signals from peripheral C-nerve fibers to neurons in the spinal cord and brain. A variety of neural mediators may be involved in this process. (See <a href=\"#H690760\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H690767\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pruritic disorders can be classified as dermatologic, systemic, neurologic, or psychogenic causes of pruritus. Dermatologic disorders typically present with skin findings that indicate the presence of a primary skin disorder. Secondary signs of pruritus, such as excoriations, skin lichenification, and skin hyperpigmentation may also be present. (See <a href=\"#H690774\" class=\"local\">'Classification'</a> above and <a href=\"#H690788\" class=\"local\">'Dermatologic disorders'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple systemic disorders, some of which are associated with significant morbidity, may present with symptoms of pruritus (<a href=\"image.htm?imageKey=DERM%2F74678\" class=\"graphic graphic_table graphicRef74678 \">table 1</a>). Pruritus may be the initial sign of disease in patients with hematologic malignancies. Pruritus related to solid tumors is uncommon. (See <a href=\"#H690865\" class=\"local\">'Systemic disorders'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A key component of the evaluation of patients with pruritus is the assessment of whether a primary skin disorder is present (<a href=\"image.htm?imageKey=DERM%2F80780\" class=\"graphic graphic_algorithm graphicRef80780 \">algorithm 1</a>). Primary skin lesions are subtle in some skin disorders. If primary skin lesions are identified, but the diagnosis remains uncertain, a skin biopsy can be used to assist with diagnosis. (See <a href=\"#H690998\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The possibility of a systemic disorder should be considered in patients with generalized pruritus and no evidence for primary skin lesions. Along with a careful patient history and physical examination, select laboratory studies can be useful for obtaining a diagnosis. (See <a href=\"#H690998\" class=\"local\">'Evaluation'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/1\" class=\"nounderline abstract_t\">St&auml;nder S, Sch&auml;fer I, Phan NQ, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 2010; 221:229.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/2\" class=\"nounderline abstract_t\">Dalgard F, Svensson A, Holm J&Oslash;, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Investig Dermatol Symp Proc 2004; 9:120.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/3\" class=\"nounderline abstract_t\">Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17:8003.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/4\" class=\"nounderline abstract_t\">Reddy VB, Iuga AO, Shimada SG, et al. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci 2008; 28:4331.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/5\" class=\"nounderline abstract_t\">Sun YG, Zhao ZQ, Meng XL, et al. Cellular basis of itch sensation. Science 2009; 325:1531.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/6\" class=\"nounderline abstract_t\">Davidson S, Giesler GJ. The multiple pathways for itch and their interactions with pain. Trends Neurosci 2010; 33:550.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/7\" class=\"nounderline abstract_t\">Namer B, Carr R, Johanek LM, et al. Separate peripheral pathways for pruritus in man. J Neurophysiol 2008; 100:2062.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/8\" class=\"nounderline abstract_t\">Davidson S, Zhang X, Yoon CH, et al. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 2007; 27:10007.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/9\" class=\"nounderline abstract_t\">Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007; 127:1857.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/10\" class=\"nounderline abstract_t\">Yosipovitch G. Recent advances in pruritus - what we have learned and where are we headed. F1000 Med Rep 2010; 2.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/11\" class=\"nounderline abstract_t\">Metz M, St&auml;nder S. Chronic pruritus--pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010; 24:1249.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/12\" class=\"nounderline abstract_t\">Sanders KM, Nattkemper LA, Yosipovitch G. Advances in understanding itching and scratching: a new era of targeted treatments. F1000Res 2016; 5.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/13\" class=\"nounderline abstract_t\">Ikoma A, Steinhoff M, St&auml;nder S, et al. The neurobiology of itch. Nat Rev Neurosci 2006; 7:535.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/14\" class=\"nounderline abstract_t\">Ishiuji Y, Coghill RC, Patel TS, et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009; 161:1072.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/15\" class=\"nounderline abstract_t\">Davidson S, Zhang X, Khasabov SG, et al. Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci 2009; 12:544.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/16\" class=\"nounderline abstract_t\">Yosipovitch G, Ishiuji Y, Patel TS, et al. The brain processing of scratching. J Invest Dermatol 2008; 128:1806.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/17\" class=\"nounderline abstract_t\">Ishiuji Y, Coghill RC, Patel TS, et al. Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis. Br J Dermatol 2008; 158:78.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/18\" class=\"nounderline abstract_t\">St&auml;nder S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87:291.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/19\" class=\"nounderline abstract_t\">Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med 2013; 368:1625.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/20\" class=\"nounderline abstract_t\">White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. Clin Dermatol 2011; 29:37.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/21\" class=\"nounderline abstract_t\">Millikan LE. Treating pruritus. What's new in safe relief of symptoms? Postgrad Med 1996; 99:173.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/22\" class=\"nounderline abstract_t\">Dawn A, Papoiu AD, Chan YH, et al. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160:642.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/23\" class=\"nounderline abstract_t\">Mollanazar NK, Smith PK, Yosipovitch G. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clin Rev Allergy Immunol 2016; 51:263.</a></li><li class=\"breakAll\">Yosipovitch G. Epidemiology of itching in skin and systemic disease. In: Itch: Basic mechanisms and therapy, Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F (Eds), Marcel Dekker, Inc., New York 2004. p.183.</li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/25\" class=\"nounderline abstract_t\">Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol 2002; 46:645.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/26\" class=\"nounderline abstract_t\">Greco PJ, Ende J. Pruritus: a practical approach. J Gen Intern Med 1992; 7:340.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/27\" class=\"nounderline abstract_t\">Konuk N, Koca R, Atik L, et al. Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 2007; 29:232.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/28\" class=\"nounderline abstract_t\">Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137:280.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/29\" class=\"nounderline abstract_t\">Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143:969.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/30\" class=\"nounderline abstract_t\">Chosidow O. Clinical practices. Scabies. N Engl J Med 2006; 354:1718.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/31\" class=\"nounderline abstract_t\">Bakker CV, Terra JB, Pas HH, Jonkman MF. Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol 2013; 149:950.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/32\" class=\"nounderline abstract_t\">Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant 1995; 10:2174.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/33\" class=\"nounderline abstract_t\">St&aring;hle-B&auml;ckdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1989; 145:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/34\" class=\"nounderline abstract_t\">Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34:136.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/35\" class=\"nounderline abstract_t\">Gilchrest BA, Stern RS, Steinman TI, et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 1982; 118:154.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/36\" class=\"nounderline abstract_t\">Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis 2007; 50:11.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/37\" class=\"nounderline abstract_t\">Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010; 49:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/38\" class=\"nounderline abstract_t\">Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management. Dermatol Clin 2002; 20:459.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/39\" class=\"nounderline abstract_t\">Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139:1008.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/40\" class=\"nounderline abstract_t\">Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010; 23:590.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/41\" class=\"nounderline abstract_t\">Rowe B, Yosipovitch G. Malignancy-associated pruritus. Eur J Pain 2016; 20:19.</a></li><li class=\"breakAll\">Yosipovitch G. Epidemiology of itching in skin and systemic disease. In: Itch: Basic mechanisms and therapy, Yosipovitch G, Greaves MW, Fleischer Jr AB, McGlone F (Eds), Marcel Dekker, Inc., New York 2004. p.183.</li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/43\" class=\"nounderline abstract_t\">Siegel FP, Tauscher J, Petrides PE. Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients. Am J Hematol 2013; 88:665.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/44\" class=\"nounderline abstract_t\">Lober CW. Should the patient with generalized pruritus be evaluated for malignancy? J Am Acad Dermatol 1988; 19:350.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/45\" class=\"nounderline abstract_t\">Pujol RM, Gallardo F, Llistosella E, et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol 2002; 47:S168.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/46\" class=\"nounderline abstract_t\">Fett N, Haynes K, Propert KJ, Margolis DJ. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices. J Am Acad Dermatol 2014; 70:651.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/47\" class=\"nounderline abstract_t\">Johannesdottir SA, Farkas DK, Vinding GR, et al. Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol 2014; 171:839.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/48\" class=\"nounderline abstract_t\">Neilly JB, Martin A, Simpson N, MacCuish AC. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986; 9:273.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/49\" class=\"nounderline abstract_t\">Scribner M. Diabetes and pruritus of the scalp. JAMA 1977; 237:1559.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/50\" class=\"nounderline abstract_t\">Yamaoka H, Sasaki H, Yamasaki H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010; 33:150.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/51\" class=\"nounderline abstract_t\">Blanes M, Belinch&oacute;n I, Portilla J, et al. Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: a study of its prevalence and causes. Int J STD AIDS 2012; 23:255.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/52\" class=\"nounderline abstract_t\">Kaushik SB, Cerci FB, Miracle J, et al. Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol 2014; 70:659.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/53\" class=\"nounderline abstract_t\">Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361:690.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/54\" class=\"nounderline abstract_t\">Garman ME, Tyring SK. The cutaneous manifestations of HIV infection. Dermatol Clin 2002; 20:193.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/55\" class=\"nounderline abstract_t\">Shirani Z, Kucenic MJ, Carroll CL, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol 2004; 29:273.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/56\" class=\"nounderline abstract_t\">Razykov I, Thombs BD, Hudson M, et al. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum 2009; 61:1765.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/57\" class=\"nounderline abstract_t\">El-Baalbaki G, Razykov I, Hudson M, et al. Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62:1489.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/58\" class=\"nounderline abstract_t\">Haber JS, Valdes-Rodriguez R, Yosipovitch G. Chronic Pruritus and Connective Tissue Disorders: Review, Gaps, and Future Directions. Am J Clin Dermatol 2016; 17:445.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/59\" class=\"nounderline abstract_t\">Valdes-Rodriguez R, Rowe B, Lee HG, et al. Chronic Pruritus in Primary Sj&ouml;gren's Syndrome: Characteristics and Effect on Quality of Life. Acta Derm Venereol 2017; 97:385.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/60\" class=\"nounderline abstract_t\">Szarvas S, Harmon D, Murphy D. Neuraxial opioid-induced pruritus: a review. J Clin Anesth 2003; 15:234.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/61\" class=\"nounderline abstract_t\">Joshi SS, Ortiz S, Witherspoon JN, et al. Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life. Cancer 2010; 116:3916.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/62\" class=\"nounderline abstract_t\">Manousaridis I, Mavridou S, Goerdt S, et al. Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management. J Eur Acad Dermatol Venereol 2013; 27:11.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/63\" class=\"nounderline abstract_t\">Hanaizi Z, van Zwieten-Boot B, Calvo G, et al. The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products for Human Use. Eur J Cancer 2012; 48:237.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/64\" class=\"nounderline abstract_t\">Fischer A, Rosen AC, Ensslin CJ, et al. Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4. Dermatol Ther 2013; 26:135.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/65\" class=\"nounderline abstract_t\">Reich A, St&auml;nder S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol 2009; 89:236.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/66\" class=\"nounderline abstract_t\">Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology 2011; 53:1377.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/67\" class=\"nounderline abstract_t\">Lane JE, McKenzie JT, Spiegel J. Brachioradial pruritus: a case report and review of the literature. Cutis 2008; 81:37.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/68\" class=\"nounderline abstract_t\">Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol 2005; 52:1073.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/69\" class=\"nounderline abstract_t\">Mirzoyev SA, Davis MD. Brachioradial pruritus: Mayo Clinic experience over the past decade. Br J Dermatol 2013; 169:1007.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/70\" class=\"nounderline abstract_t\">Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005; 52:142.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/71\" class=\"nounderline abstract_t\">Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003; 48:521.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/72\" class=\"nounderline abstract_t\">Marziniak M, Phan NQ, Raap U, et al. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol 2011; 65:756.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/73\" class=\"nounderline abstract_t\">Kavak A, Dosoglu M. Can a spinal cord tumor cause brachioradial pruritus? J Am Acad Dermatol 2002; 46:437.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/74\" class=\"nounderline abstract_t\">Fleuret C, Dupr&eacute;-Goetghebeur D, Person H, et al. [Brachioradial pruritus revealing an ependymoma]. Ann Dermatol Venereol 2009; 136:435.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/75\" class=\"nounderline abstract_t\">Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005; 52:1085.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/76\" class=\"nounderline abstract_t\">Oaklander AL, Bowsher D, Galer B, et al. Herpes zoster itch: preliminary epidemiologic data. J Pain 2003; 4:338.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/77\" class=\"nounderline abstract_t\">Wood GJ, Akiyama T, Carstens E, et al. An insatiable itch. J Pain 2009; 10:792.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/78\" class=\"nounderline abstract_t\">Koeppel MC, Bramont C, Ceccaldi M, et al. Paroxysmal pruritus and multiple sclerosis. Br J Dermatol 1993; 129:597.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/79\" class=\"nounderline abstract_t\">Brenaut E, Marcorelles P, Genestet S, et al. Pruritus: an underrecognized symptom of small-fiber neuropathies. J Am Acad Dermatol 2015; 72:328.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/80\" class=\"nounderline abstract_t\">Nakamizo S, Miyachi Y, Kabashima K. Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin. Acta Derm Venereol 2010; 90:654.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/81\" class=\"nounderline abstract_t\">Cohen OS, Chapman J, Lee H, et al. Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology. J Neurol 2011; 258:89.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/82\" class=\"nounderline abstract_t\">Shabtai H, Nisipeanu P, Chapman J, Korczyn AD. Pruritus in Creutzfeldt-Jakob disease. Neurology 1996; 46:940.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/83\" class=\"nounderline abstract_t\">Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry 2008; 30:344.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/84\" class=\"nounderline abstract_t\">Yamamoto Y, Yamazaki S, Hayashino Y, et al. Association between frequency of pruritic symptoms and perceived psychological stress: a Japanese population-based study. Arch Dermatol 2009; 145:1384.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/85\" class=\"nounderline abstract_t\">Fruensgaard K. Neurotic excoriations. A controlled psychiatric examination. Acta Psychiatr Scand Suppl 1984; 312:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/86\" class=\"nounderline abstract_t\">Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15:351.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/87\" class=\"nounderline abstract_t\">Mutasim DF, Adams BB. The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol 2009; 61:611.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/88\" class=\"nounderline abstract_t\">van Laarhoven AI, Walker AL, Wilder-Smith OH, et al. Role of induced negative and positive emotions in sensitivity to itch and pain in women. Br J Dermatol 2012; 167:262.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/89\" class=\"nounderline abstract_t\">Papoiu AD, Wang H, Coghill RC, et al. Contagious itch in humans: a study of visual 'transmission' of itch in atopic dermatitis and healthy subjects. Br J Dermatol 2011; 164:1299.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/90\" class=\"nounderline abstract_t\">Schut C, Grossman S, Gieler U, et al. Contagious itch: what we know and what we would like to know. Front Hum Neurosci 2015; 9:57.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/91\" class=\"nounderline abstract_t\">Berger TG, Shive M, Harper GM. Pruritus in the older patient: a clinical review. JAMA 2013; 310:2443.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/92\" class=\"nounderline abstract_t\">Namer B. Age related changes in human C-fiber function. Neurosci Lett 2010; 470:185.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/93\" class=\"nounderline abstract_t\">Valdes-Rodriguez R, Mollanazar NK, Gonz&aacute;lez-Muro J, et al. Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire. Acta Derm Venereol 2015; 95:417.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/94\" class=\"nounderline abstract_t\">Rimoin LP, Kwatra SG, Yosipovitch G. Female-specific pruritus from childhood to postmenopause: clinical features, hormonal factors, and treatment considerations. Dermatol Ther 2013; 26:157.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/95\" class=\"nounderline abstract_t\">St&auml;nder S, Stumpf A, Osada N, et al. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 2013; 168:1273.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/96\" class=\"nounderline abstract_t\">Van Loey NE, Bremer M, Faber AW, et al. Itching following burns: epidemiology and predictors. Br J Dermatol 2008; 158:95.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/97\" class=\"nounderline abstract_t\">Lee SS, Yosipovitch G, Chan YH, Goh CL. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 2004; 51:1002.</a></li><li><a href=\"https://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation/abstract/98\" class=\"nounderline abstract_t\">Papa CM. Winter itch, dry skin. J Med Soc N J 1980; 77:817.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 16589 Version 21.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H691026\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H690753\" id=\"outline-link-H690753\">INTRODUCTION</a></li><li><a href=\"#H690760\" id=\"outline-link-H690760\">EPIDEMIOLOGY</a></li><li><a href=\"#H690767\" id=\"outline-link-H690767\">PATHOGENESIS</a></li><li><a href=\"#H690774\" id=\"outline-link-H690774\">CLASSIFICATION</a></li><li><a href=\"#H690781\" id=\"outline-link-H690781\">ETIOLOGY</a><ul><li><a href=\"#H690788\" id=\"outline-link-H690788\">Dermatologic disorders</a><ul><li><a href=\"#H690795\" id=\"outline-link-H690795\">- Xerosis</a></li><li><a href=\"#H690802\" id=\"outline-link-H690802\">- Atopic dermatitis</a></li><li><a href=\"#H690809\" id=\"outline-link-H690809\">- Contact dermatitis</a></li><li><a href=\"#H690816\" id=\"outline-link-H690816\">- Urticaria</a></li><li><a href=\"#H690823\" id=\"outline-link-H690823\">- Dermatophytosis</a></li><li><a href=\"#H690830\" id=\"outline-link-H690830\">- Lichen simplex chronicus</a></li><li><a href=\"#H690837\" id=\"outline-link-H690837\">- Psoriasis</a></li><li><a href=\"#H690844\" id=\"outline-link-H690844\">- Scabies</a></li><li><a href=\"#H690851\" id=\"outline-link-H690851\">- Pediculosis corporis and pubis</a></li><li><a href=\"#H1120095\" id=\"outline-link-H1120095\">- Bullous pemphigoid</a></li><li><a href=\"#H690858\" id=\"outline-link-H690858\">- Allergies</a></li></ul></li><li><a href=\"#H690865\" id=\"outline-link-H690865\">Systemic disorders</a><ul><li><a href=\"#H690872\" id=\"outline-link-H690872\">- Renal disease</a></li><li><a href=\"#H690879\" id=\"outline-link-H690879\">- Cholestasis</a></li><li><a href=\"#H690886\" id=\"outline-link-H690886\">- Malignancy</a></li><li><a href=\"#H690893\" id=\"outline-link-H690893\">- Thyroid disorders</a></li><li><a href=\"#H690900\" id=\"outline-link-H690900\">- Diabetes</a></li><li><a href=\"#H690907\" id=\"outline-link-H690907\">- HIV</a></li><li><a href=\"#H693620\" id=\"outline-link-H693620\">- Connective tissue diseases</a></li><li><a href=\"#H690914\" id=\"outline-link-H690914\">- Medication</a></li></ul></li><li><a href=\"#H690921\" id=\"outline-link-H690921\">Neurologic disorders (neuropathic itch)</a><ul><li><a href=\"#H690928\" id=\"outline-link-H690928\">- Brachioradial pruritus</a></li><li><a href=\"#H690935\" id=\"outline-link-H690935\">- Notalgia paresthetica</a></li><li><a href=\"#H690942\" id=\"outline-link-H690942\">- Postherpetic neuralgia</a></li><li><a href=\"#H690949\" id=\"outline-link-H690949\">- Multiple sclerosis</a></li><li><a href=\"#H690956\" id=\"outline-link-H690956\">- Other</a></li></ul></li><li><a href=\"#H690963\" id=\"outline-link-H690963\">Psychogenic itch</a></li><li><a href=\"#H690970\" id=\"outline-link-H690970\">Other associations</a><ul><li><a href=\"#H690977\" id=\"outline-link-H690977\">- Advanced age</a></li><li><a href=\"#H88784958\" id=\"outline-link-H88784958\">- Sex</a></li><li><a href=\"#H690984\" id=\"outline-link-H690984\">- Burns and scars</a></li></ul></li></ul></li><li><a href=\"#H690998\" id=\"outline-link-H690998\">EVALUATION</a><ul><li><a href=\"#H691005\" id=\"outline-link-H691005\">Pruritus with primary skin lesions</a></li><li><a href=\"#H691012\" id=\"outline-link-H691012\">Generalized pruritus without primary skin lesions</a></li><li><a href=\"#H691019\" id=\"outline-link-H691019\">Localized pruritus without primary skin lesions</a></li></ul></li><li><a href=\"#H691026\" id=\"outline-link-H691026\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/16589|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=DERM/80780\" class=\"graphic graphic_algorithm\">- Algorithm for the evaluation of pruritus</a></li></ul></li><li><div id=\"DERM/16589|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/67366\" class=\"graphic graphic_picture\">- Xerosis</a></li><li><a href=\"image.htm?imageKey=PC/52163\" class=\"graphic graphic_picture\">- Flexural atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=PC/71913\" class=\"graphic graphic_picture\">- Allergic contact dermatitis</a></li><li><a href=\"image.htm?imageKey=PC/71834\" class=\"graphic graphic_picture\">- Irritant contact dermatitis</a></li><li><a href=\"image.htm?imageKey=PC/72519\" class=\"graphic graphic_picture\">- Urticaria 1</a></li><li><a href=\"image.htm?imageKey=ID/81678\" class=\"graphic graphic_picture\">- Giant urticaria</a></li><li><a href=\"image.htm?imageKey=PC/56684\" class=\"graphic graphic_picture\">- Tinea cruris</a></li><li><a href=\"image.htm?imageKey=DERM/76067\" class=\"graphic graphic_picture\">- Tinea pedis interdigital maceration</a></li><li><a href=\"image.htm?imageKey=PC/54214\" class=\"graphic graphic_picture\">- Acute tinea pedis</a></li><li><a href=\"image.htm?imageKey=DERM/86628\" class=\"graphic graphic_picture\">- Tinea capitis - black dot</a></li><li><a href=\"image.htm?imageKey=DERM/73843\" class=\"graphic graphic_picture\">- Lichen simplex chronicus ankle</a></li><li><a href=\"image.htm?imageKey=PC/51161\" class=\"graphic graphic_picture\">- Interdigital scabies</a></li><li><a href=\"image.htm?imageKey=PC/53894\" class=\"graphic graphic_picture\">- Penile scabies</a></li><li><a href=\"image.htm?imageKey=DERM/53715\" class=\"graphic graphic_picture\">- Scabies burrow 2</a></li><li><a href=\"image.htm?imageKey=DERM/73592\" class=\"graphic graphic_picture\">- Pediculosis corporis 2</a></li><li><a href=\"image.htm?imageKey=PC/55191\" class=\"graphic graphic_picture\">- Pediculosis pubis</a></li><li><a href=\"image.htm?imageKey=DERM/87125\" class=\"graphic graphic_picture\">- HIV-associated eosinophilic folliculitis</a></li><li><a href=\"image.htm?imageKey=DERM/56937\" class=\"graphic graphic_picture\">- Notalgia paresthetica</a></li><li><a href=\"image.htm?imageKey=ALLRG/50823\" class=\"graphic graphic_picture\">- Dermatographism 1</a></li></ul></li><li><div id=\"DERM/16589|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/74678\" class=\"graphic graphic_table\">- Causes of pruritus</a></li><li><a href=\"image.htm?imageKey=PC/57187\" class=\"graphic graphic_table\">- Dx criteria atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=DERM/87630\" class=\"graphic graphic_table\">- Examples of drugs that may cause pruritus</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-dermatologic-diagnosis\" class=\"medical medical_review\">Approach to dermatologic diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">Clinical features and diagnosis of allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-of-multiple-sclerosis-in-adults\" class=\"medical medical_review\">Clinical features of multiple sclerosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-of-the-carcinoid-syndrome\" class=\"medical medical_review\">Clinical features of the carcinoid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-laboratory-manifestations-and-diagnosis-of-multiple-myeloma\" class=\"medical medical_review\">Clinical features, laboratory manifestations, and diagnosis of multiple myeloma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-polycythemia-vera\" class=\"medical medical_review\">Clinical manifestations and diagnosis of polycythemia vera</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">Clinical manifestations of dermatomyositis and polymyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-hypothyroidism\" class=\"medical medical_review\">Clinical manifestations of hypothyroidism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-primary-biliary-cholangitis-primary-biliary-cirrhosis\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and prognosis of primary biliary cholangitis (primary biliary cirrhosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">Clinical presentation and diagnosis of non-Hodgkin lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia\" class=\"medical medical_review\">Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cocaine-use-disorder-in-adults-epidemiology-pharmacology-clinical-manifestations-medical-consequences-and-diagnosis\" class=\"medical medical_review\">Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-manifestations-of-internal-malignancy\" class=\"medical medical_review\">Cutaneous manifestations of internal malignancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=delusional-infestation-epidemiology-clinical-presentation-assessment-and-diagnosis\" class=\"medical medical_review\">Delusional infestation: Epidemiology, clinical presentation, assessment and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatoses-of-pregnancy\" class=\"medical medical_review\">Dermatoses of pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=grovers-disease-transient-and-persistent-acantholytic-dermatosis\" class=\"medical medical_review\">Grover's disease (transient and persistent acantholytic dermatosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">HIV-associated eosinophilic folliculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-management-of-cutaneous-dermatomyositis-in-adults\" class=\"medical medical_review\">Initial management of cutaneous dermatomyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intrahepatic-cholestasis-of-pregnancy\" class=\"medical medical_review\">Intrahepatic cholestasis of pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=irritant-contact-dermatitis-in-adults\" class=\"medical medical_review\">Irritant contact dermatitis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=keloids-and-hypertrophic-scars\" class=\"medical medical_review\">Keloids and hypertrophic scars</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methamphetamine-use-disorder-epidemiology-clinical-manifestations-course-assessment-and-diagnosis\" class=\"medical medical_review\">Methamphetamine use disorder: Epidemiology, clinical manifestations, course, assessment, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">New-onset urticaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=opioid-use-disorder-epidemiology-pharmacology-clinical-manifestations-course-screening-assessment-and-diagnosis\" class=\"medical medical_review\">Opioid use disorder: Epidemiology, pharmacology, clinical manifestations, course, screening, assessment, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-hyperthyroidism-in-adults\" class=\"medical medical_review\">Overview of the clinical manifestations of hyperthyroidism in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-sclerosis-scleroderma-in-adults\" class=\"medical medical_review\">Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vulvovaginal-complaints-in-the-prepubertal-child\" class=\"medical medical_review\">Overview of vulvovaginal complaints in the prepubertal child</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pediculosis-corporis\" class=\"medical medical_review\">Pediculosis corporis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pediculosis-pubis-and-pediculosis-ciliaris\" class=\"medical medical_review\">Pediculosis pubis and pediculosis ciliaris</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=physical-urticarias\" class=\"medical medical_review\">Physical urticarias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pruritus-associated-with-cholestasis\" class=\"medical medical_review\">Pruritus associated with cholestasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pruritus-overview-of-management\" class=\"medical medical_review\">Pruritus: Overview of management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Scabies: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-picking-excoriation-disorder-and-related-disorders\" class=\"medical medical_review\">Skin picking (excoriation) disorder and related disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-minor-thermal-burns\" class=\"medical medical_review\">Treatment of minor thermal burns</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uremic-pruritus\" class=\"medical medical_review\">Uremic pruritus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vulvar-dermatitis\" class=\"medical medical_review\">Vulvar dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vulvar-lesions-differential-diagnosis-based-on-morphology\" class=\"medical medical_review\">Vulvar lesions: Differential diagnosis based on morphology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vulvar-lichen-planus\" class=\"medical medical_review\">Vulvar lichen planus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vulvar-lichen-sclerosus\" class=\"medical medical_review\">Vulvar lichen sclerosus</a></li></ul></div></div>","javascript":null}